Avastin

Results from the phase III IMbrave150 study evaluating Atezolizumab ( Tecentriq ) in combination with Bevacizumab ( Avastin ) were...


The FDA ( US Food and Drug Administration ) has approved Tecentriq ( Atezolizumab ) in combination with chemotherapy (...


Non-clear cell renal cell carcinoma ( NccRCC ) and clear cell renal cell carcinoma with sarcomatoid differentiation ( sccRCC )...


Updated preliminary clinical data from an ongoing phase I dose escalation and expansion study evaluating the safety and efficacy of...



Compared with traditional chemotherapy, targeted cancer therapy is a novel strategy in which key molecules in signaling pathways involved in...


The Chemotherapy Clinical Reference Group ( CRG ) has reviewed drugs and drug indications for inclusion on the National cancer...


A single-practice retrospective chart review has reported on long-term visual outcomes in patients receiving continuous fixed-interval dosing of anti-vascular endothelial...


The European Commission ( EU ) has approved the use of Avastin ( Bevacizumab ) in combination with Paclitaxel, Topotecan,...


Bevacizumab ( Avastin ), a monoclonal antibody that targets VEGF, has shown restricted activity in patients with advanced melanoma. A...


Standard therapy for newly diagnosed glioblastoma is radiotherapy plus Temozolomide ( Temodal ). In this phase 3 study, researchers have...


Prolonging first-line chemotherapy results with maintenance treatment may influence overall survival. In HER2-negative patients with locally recurrent/metastatic breast cancer, combining...


Combining Bevacizumab ( Avastin ) with first- or second-line chemotherapy in randomised phase III trials showed significantly improved progression-free survival...


Glioblastoma ( GBM ) is the most common primary malignant adult brain tumor and, despite treatment advances in recent years,...


Preclinical data suggest that triple-negative breast cancers are sensitive to interstrand crosslinking agents, and that synergy may exist for the...


Roche has announced that the EU Committee for Medicinal Products for Human Use ( CHMP ) has recommended that the...


Bevacizumab ( Avastin ), a monoclonal antibody that targets VEGF, has shown restricted activity in patients with advanced melanoma. A...


Interim analysis of a large, randomized clinical trial has shown that patients with advanced, recurrent, or persistent cervical cancer that...


Glioblastoma is the most common primary malignant brain tumor in adults and, despite treatment advances in recent years, the average...


The aim of the GEFAL trial was to evaluate the relative efficacy and safety profile of Bevacizumab ( Avastin )...